| Literature DB >> 28927023 |
Hyo-Rim Lee1,2, Sung-Chan Lee3, Ji-Eun Lee4, Seon-Mi Seo5,6, Yong-Chul Jeong7, Chan-Sik Jung8, Mark G Moloney9, Il-Kwon Park10,11.
Abstract
Among 98 3-acyltetramic acid analogues, compounds 1c, 2c, 2f and 2g, showed >90% nematicidal activity against the pine wood nematode Bursaphelenchus xylophilus at a 10 μg/mL concentration. The nematicidal activities of compounds 1d, 1h, and 2k were a little lower at 88.0%, 85.8%, and 57.2% at a 10 μg/mL concentration, respectively. The nematicidal activity of emamection benzoate, widely used in Korea for the prevention of pine wilt disease, was 32.3% at a 10 μg/mL concentration. Other 3-acyltetramic acid analogues showed less than 30% nematicidal activity. A structure-activity relationship study indicated that the chain length of the C-acyl substituent was very important for high nematicidal activity. All active compounds had C13H27 or C11H23 acyl substituents, in two closely related groups with the common physicochemical properties of a polar surface area 57.6A², PSA (polar surface area) 7.8-8.6% and ClogP (calculated partition coefficient) 5.1-5.9 and a polar surface area 75-84A², PSA 11.1-11.6% and ClogP 4.7-5.1, respectively. Our study indicates that active 3-acyltetramic acid analogues could have potential as lead compounds for developing novel pine wood nematode control agents.Entities:
Keywords: 3-acyltetramic acid analogues; lead compounds; pine wilt disease; pine wood nematode; toxicity
Mesh:
Substances:
Year: 2017 PMID: 28927023 PMCID: PMC6151501 DOI: 10.3390/molecules22091568
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of monocyclic 3-acyltetramic acid analogues.
Figure 2Chemical structures of 3-acyltetramic acid analogues.
Nematicidal activities of 3-acyltetramic acid analogues against B. xylophilus.
| Compounds 1 | Mortality (%, Mean ± SE, | ||
|---|---|---|---|
| 10 2 | 5 | 2.5 | |
| 99.6 ± 0.7a 3 | 96.2 ± 0.9a | 15.0 ± 3.0bc | |
| 85.8 ± 3.5a | 80.2 ± 6.8ab | 35.5 ± 3.2a | |
| 88.0 ± 7.3a | 0.7 ± 1.3e | − 4 | |
| 100a | 66.8 ± 8.1bc | 6.3 ± 0.5cd | |
| 95.8 ± 1.1a | 76.4 ± 3.1b | 10.8 ± 2.8c | |
| 98.9 ± 1.9a | 96.4 ± 1.8a | 6.3 ± 3.6cd | |
| 57.2 ± 18.8b | 50.6 ± 10.1c | 13.1 ± 3.9c | |
| Emamectin benzoate | 32.3 ± 2.7c | 28.2 ± 3.9d | 24.1 ± 4.3b |
| Control | 0d | 0e | 0d |
| F8, 27 = 80.208 | F8, 27 = 156.542 | F7, 24 = 41.067 | |
Compounds 1 with >30% mortality at 10 μg/mL are shown. 2 μg/mL. 3 Means within a column followed by the same letters are not significantly different (Scheffe’s test). 4 Not tested.
Physicochemical properties of active 3-acyltetramic acid analogues.
| Compounds | Mw 1 | MSA(A 3) 2 | PSA(A 2) 3 | rel-PSA (%) 4 | ClogP 5 | ClogD7.4 6 | H-D 7/H-A 8 | RB 9 |
|---|---|---|---|---|---|---|---|---|
| 366 | 674 | 57.6 | 8.55 | 5.12 | 4.51 | 1/3 | 15 | |
| 394 | 735 | 57.6 | 7.84 | 5.92 | 5.30 | 1/3 | 17 | |
| 410 | 721 | 83.9 | 11.6 | 5.13 | 4.26 | 1/4 | 14 | |
| 380 | 673 | 74.7 | 11.1 | 4.69 | 3.91 | 1/4 | 14 | |
| 366 | 674 | 57.6 | 8.55 | 5.12 | 4.51 | 1/3 | 15 | |
| 394 | 735 | 57.6 | 7.84 | 5.92 | 5.30 | 1/3 | 17 | |
| 378 | 642 | 74.7 | 11.6 | 4.77 | 3.92 | 1/4 | 13 |
Mw 1: Molecular weight. MSA 2: Molecular surface area. PSA 3: Polar surface area. rel-PSA 4: Relative polar surface area (%) = (PSA/MSA) × 100. ClogP 5: Calculated partition coefficient. ClogD7.4 6: Calculated distribution coefficient at pH 7.4. H-D 7: Hydrogen bond donor count. H-A 8: Hydrogen bond acceptor count. RB 9: Rotatable bond count.